Cargando…

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

Detalles Bibliográficos
Autores principales:	Earl, H.M., Hiller, L., Dunn, J., Macpherson, I., Rea, D., Hughes-Davies, L., McAdam, K., Hall, P., Mansi, J., Wheatley, D., Abraham, J.E., Caldas, C., Gasson, S., O'Riordan, E., Wilcox, M., Miles, D., Cameron, D.A., Wardley, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal College of Radiologists. Published by Elsevier Ltd. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382576/ https://www.ncbi.nlm.nih.gov/pubmed/32723485 http://dx.doi.org/10.1016/j.clon.2020.07.006

Ejemplares similares

Trastuzumab-associated cardiac events in the Persephone trial
por: Earl, Helena M, et al.
Publicado: (2016)

Adjuvant trastuzumab duration trials in HER2 positive breast cancer – what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results
por: Hiller, Louise, et al.
Publicado: (2018)

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
por: Earl, Helena M, et al.
Publicado: (2019)

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
por: Clayton, A J, et al.
Publicado: (2004)

Optimising patient recall of adverse events over prolonged time periods
por: Hiller, Louise, et al.
Publicado: (2011)

Guía de los padres para los primeros auxilios
por: O'Riordan, William D.
Publicado: (1983)

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial
por: Earl, H. M., et al.
Publicado: (2017)

tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation
por: Wardley, A M, et al.
Publicado: (2008)

NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life
por: Earl, H M, et al.
Publicado: (2008)

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
por: Jones, A L, et al.
Publicado: (2009)

Turn-around procedure and its optimisation
por: Miles, J
Publicado: (1993)

[(64)Cu]‐labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice
por: Schjoeth‐Eskesen, Christina, et al.
Publicado: (2015)

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials
por: Earl, H M, et al.
Publicado: (2012)

Severe hypoglycemia with trastuzumab: An unseen adverse event
por: Amrith, B. P., et al.
Publicado: (2019)

Successful Endoscopic Management of Bouveret's Syndrome in a Patient with Cholecystoduodenocolic Fistulae
por: Tanwar, S., et al.
Publicado: (2008)

Synthesising existing research on complicated grief in intellectual disability: findings from a systematic review
por: O'Riordan, D., et al.
Publicado: (2022)

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration
por: Wardley, A, et al.
Publicado: (2005)

Optimisation of platelet concentrates therapy: Composition, localisation, and duration of action
por: Yung, Yuk-Lin, et al.
Publicado: (2017)

Optimising trial designs to identify appropriate antibiotic treatment durations
por: Pouwels, Koen B., et al.
Publicado: (2019)

Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children
por: Morgan, Jessica E, et al.
Publicado: (2021)

XIAP Regulates Cytosol-Specific Innate Immunity to Listeria Infection
por: Bauler, Laura D., et al.
Publicado: (2008)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group
por: Mackey, J.R., et al.
Publicado: (2008)

Optimising Cognitive Enhancement: Systematic Assessment of the Effects of tDCS Duration in Older Adults
por: Hanley, Claire J., et al.
Publicado: (2020)

Neonatal Care and Data
por: O'Riordan, Declan, et al.
Publicado: (2009)

More Than a Pore: The Cellular Response to Cholesterol-Dependent Cytolysins
por: Cassidy, Sara K. B., et al.
Publicado: (2013)

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies
por: Powell, C.A., et al.
Publicado: (2022)

Effect of concrete slats, three mat types and out-wintering pads on performance and welfare of finishing beef steers
por: Earley, Bernadette, et al.
Publicado: (2017)

Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death having features of apoptosis and pyroptosis
por: Bronner, Denise N., et al.
Publicado: (2013)

Conference on Becquerel's Legacy: a Century of Radioactivity
por: O'Riordan, M C
Publicado: (1996)

Reflections from a breast surgeon with breast cancer on how to improve cancer care
por: O’Riordan, Elizabeth Louise
Publicado: (2019)

Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer
por: Levicki, Rea, et al.
Publicado: (2023)

Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling
por: Naderi, Ali, et al.
Publicado: (2004)

Enzyme Activity in Relation to Cancer: The Urinary β-Glucuronidase Activity of Patients Suffering from Malignant Disease
por: Boyland, E., et al.
Publicado: (1957)

Rethinking non-inferiority: a practical trial design for optimising treatment duration
por: Quartagno, Matteo, et al.
Publicado: (2018)

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer
por: Palmieri, Carlo, et al.
Publicado: (2015)

Optimisation of Mycobacterium bovis BCG Fermentation and Storage Survival
por: Pascoe, Jordan, et al.
Publicado: (2020)

Optimisation of the CLIC Baseline Collimation system
por: Resta-Lopez, J, et al.
Publicado: (2010)

Preparedness and management of global public health threats at points of entry in Ireland and the EU in the context of a potential Brexit
por: Boland, Máirín, et al.
Publicado: (2019)

Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection
por: Townsend, Liam, et al.
Publicado: (2020)

P.96 Development of effective and safe virtual pre-operative assessment during the Covid-19 pandemic through utilisation of telemedicine: a quality improvement project in a stand-alone maternity hospital
por: O’Riordan, E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0pr0vemk9mioummvlo6u99jeun